Results 171 to 180 of about 13,064 (207)
Some of the next articles are maybe not open access.
EphA2 as a target for ovarian cancer therapy
Expert Opinion on Therapeutic Targets, 2005EphA2 is a receptor tyrosine kinase that is overexpressed by many human cancers, and is often associated with poor prognostic features. It is involved in many processes crucial to malignant progression, such as migration, invasion, metastasis, proliferation, survival and angiogenesis.
Charles N, Landen +2 more
openaire +2 more sources
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer
Breast Cancer Research and Treatment, 2010Overexpression and altered function of EphA2 receptor tyrosine kinase are critical in the progression of breast cancer and provide a target for breast cancer therapy. We have previously demonstrated that EphA2 overexpression decreases estrogen dependence and Tamoxifen sensitivity both in vitro and in vivo.
Yesim, Gökmen-Polar +8 more
openaire +2 more sources
EphA2: A Promising Therapeutic Target in Breast Cancer
Journal of Genetics and Genomics, 2021Ceshi Chen, Dewei Jiang
exaly
EphA2 Promotes Tumorigenicity of Cervical Cancer by Up-Regulating CDK6
Journal of Cellular and Molecular Medicine, 2021Leilei Ding, Weijie Yuan, Zihua Chen
exaly
EphA2 Overexpression Correlates With Poor Prognosis in Esophageal Squamous Cell Carcinoma
International Journal of Cancer, 2003Hiroyuki Kuwano +2 more
exaly
EPHA2 Antisense RNA Modulates EPHA2 mRNA Levels in Basal-Like/Triple-Negative Breast Cancer Cells
Biochimie, 2020Tomoharu Sugie +2 more
exaly

